SA12. Baseline Demographics and Clinical Characteristics From a Prospective, Randomized, Open-Label Study of Paliperidone Palmitate Long-Acting Injection in Subjects With Recent-Onset Schizophrenia or Schizophreniform Disorder

Eitemau Tebyg

• Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder
  gan: Brown, Brianne, et al.
  Cyhoeddwyd: (2017)
• PM411. Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia
  gan: Brown, Brianne, et al.
  Cyhoeddwyd: (2016)
• Evaluation of paliperidone palmitate long‐acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia
  gan: Brown, Brianne, et al.
  Cyhoeddwyd: (2019)
• Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
  gan: Sliwa, Jennifer Kern, et al.
  Cyhoeddwyd: (2012)
• Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder
  gan: Bossie, Cynthia A., et al.
  Cyhoeddwyd: (2017)